|
CA1076114A
(en)
*
|
1975-02-10 |
1980-04-22 |
Mitsubishi Chemical Industries Limited |
1,5-alkylene-3-aryl hydantoin derivatives
|
|
DE2514992A1
(de)
*
|
1975-04-05 |
1976-10-14 |
Bayer Ag |
Fungizide mittel
|
|
US4175198A
(en)
*
|
1976-10-07 |
1979-11-20 |
W. R. Grace & Co. |
5-Secondary alkylidene hydantoins
|
|
US4147796A
(en)
*
|
1976-12-18 |
1979-04-03 |
Beecham Group Limited |
1-(3-Hydroxyalk-1-yl)-5-(carboxyalkyl)hydantoin derivatives
|
|
MC1220A1
(fr)
*
|
1977-10-28 |
1979-07-20 |
Hoffmann La Roche |
Nouveaux derives d'imidazolidine
|
|
DE3382406D1
(de)
*
|
1982-04-08 |
1991-10-17 |
Shell Int Research |
Neue hydantoine, ihre herstellung und verwendung.
|
|
DE3213140A1
(de)
*
|
1982-04-08 |
1983-10-20 |
Celamerck Gmbh & Co Kg, 6507 Ingelheim |
Cycloalkan-5'-spiro-hydrantoine, ihre herstellung und verwendung
|
|
US4464387A
(en)
*
|
1982-08-06 |
1984-08-07 |
Buffalo Color Corp. |
Insecticidal phenyl hydantoin compounds
|
|
US4473393A
(en)
*
|
1982-08-06 |
1984-09-25 |
Buffalo Color Corporation |
Pesticidal thiohydantoin compositions
|
|
US4746755A
(en)
*
|
1986-05-06 |
1988-05-24 |
The Dow Chemical Company |
Preparation of hydrantoic acids and hydantoins
|
|
FR2619381B1
(fr)
*
|
1987-08-13 |
1989-12-08 |
Roussel Uclaf |
Nouvelles imidazolidines substituees par un radical hydroxymethyle et un radical phenyl substitue, leur procede de preparation, leur application comme medicaments, les compositions pharmaceutiques les renfermant et un intermediaire pour leur preparation
|
|
FR2693461B1
(fr)
*
|
1992-07-08 |
1994-09-02 |
Roussel Uclaf |
Nouvelles phénylimidazolidines substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
|
|
US5411981A
(en)
*
|
1991-01-09 |
1995-05-02 |
Roussel Uclaf |
Phenylimidazolidines having antiandrogenic activity
|
|
US5593993A
(en)
*
|
1991-08-02 |
1997-01-14 |
Medivir Ab |
Method for inhibition of HIV related viruses
|
|
FR2694290B1
(fr)
*
|
1992-07-08 |
1994-09-02 |
Roussel Uclaf |
Nouvelles phénylimidazolidines éventuellement substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
|
|
FR2741346B1
(fr)
*
|
1995-11-16 |
1997-12-19 |
Roussel Uclaf |
Nouveau procede de preparation de derives phenylimidazolidine
|
|
US20040077605A1
(en)
|
2001-06-20 |
2004-04-22 |
Salvati Mark E. |
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
|
|
US7001911B2
(en)
|
2000-06-28 |
2006-02-21 |
Bristol-Myers Squibb Company |
Fused cyclic modulators of nuclear hormone receptor function
|
|
BR0111298A
(pt)
*
|
2000-06-28 |
2005-05-10 |
Bristol Myers Squibb Co |
Moduladores seletivos dos receptores de andrógenos e métodos para identificação, projeto e uso dos mesmos
|
|
EP1854798A3
(en)
|
2000-09-19 |
2007-11-28 |
Bristol-Myers Squibb Company |
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
|
|
US6953679B2
(en)
|
2000-09-19 |
2005-10-11 |
Bristol-Myers Squibb Company |
Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof
|
|
US20040087548A1
(en)
|
2001-02-27 |
2004-05-06 |
Salvati Mark E. |
Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
|
|
DE60228330D1
(de)
|
2001-12-19 |
2008-09-25 |
Bristol Myers Squibb Co |
Kondensierte heterocyclische verbindungen und deren analoga; modulatoren der funktion von nukleären hormonrezeptoren
|
|
US7709517B2
(en)
|
2005-05-13 |
2010-05-04 |
The Regents Of The University Of California |
Diarylhydantoin compounds
|
|
KR101456722B1
(ko)
|
2006-03-29 |
2014-10-31 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
디아릴티오히단토인 화합물
|
|
TWI469971B
(zh)
|
2007-10-26 |
2015-01-21 |
Univ California |
二芳基乙內醯脲類化合物
|
|
SG11201501870RA
(en)
|
2012-09-26 |
2015-04-29 |
Aragon Pharmaceuticals Inc |
Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
|
|
TWI726969B
(zh)
|
2016-01-11 |
2021-05-11 |
比利時商健生藥品公司 |
用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
|
|
AU2018351714A1
(en)
|
2017-10-16 |
2020-04-30 |
Aragon Pharmaceuticals, Inc. |
Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer
|